Pharmaceuticals by today's price change
How far the share price has moved since the previous close.
Legend Biotech leads the 61 pharmaceuticals ranked by today's price change, at +2.52%, ahead of Kiniksa Pharmaceuticals International (+1.71%) and Alkermes (+1.63%). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Legend Biotech+2.52%
- Median
- -0.16%
- Combined market value
- ZAR 88.23T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Legend BiotechLEGN · Health Care | +2.52% | ZAR 55.1B | ZAR 284.21 | 2.52% up | 42% down | ||
| 2 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +1.71% | ZAR 130.8B | ZAR 1,664.68 | 1.71% up | 126% up | ||
| 3 | AlkermesALKS · Health Care | +1.63% | ZAR 133.6B | ZAR 794.83 | 1.63% up | 58% up | ||
| 4 | ABIVAXABVX · Health Care | +1.61% | ZAR 125.7B | ZAR 1,435.56 | 1.61% up | 27% down | ||
| 5 | Cogent BiosciencesCOGT · Health Care | +1.44% | ZAR 84.6B | ZAR 486.15 | 1.44% up | 20% down | ||
| 6 | Dr. Reddy's LaboratoriesRDY · Health Care | +1.15% | ZAR 214.6B | ZAR 257.43 | 1.15% up | 5% up | ||
| 7 | Oruka TherapeuticsORKA · Health Care | +1.13% | ZAR 113.7B | ZAR 1,676.21 | 1.13% up | 241% up | ||
| 8 | Elanco Animal HealthELAN · Health Care | +1.01% | ZAR 224.6B | ZAR 449.30 | 1.01% up | 20% up | ||
| 9 | ZoetisZTS · Health Care | +0.98% | ZAR 589.4B | ZAR 1,450.62 | 0.98% up | 29% down | ||
| 10 | Belite BioBLTE · Health Care | +0.81% | ZAR 111.1B | ZAR 2,736.04 | 0.81% up | 31% up | ||
| 11 | Spyre TherapeuticsSYRE · Health Care | +0.75% | ZAR 154.4B | ZAR 1,626.31 | 0.75% up | 286% up | ||
| 12 | VeradermicsMANE · Health Care | +0.72% | ZAR 91.9B | ZAR 2,177.65 | 0.72% up | 233% up | ||
| 13 | Summit TherapeuticsSMMT · Health Care | +0.56% | ZAR 147.7B | ZAR 184.64 | 0.56% up | 36% down | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | +0.47% | ZAR 2.34T | ZAR 9,235.34 | 0.47% up | 27% up | ||
| 15 | CytokineticsCYTK · Health Care | +0.46% | ZAR 124.4B | ZAR 892.91 | 0.46% up | 20% down | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | +0.43% | ZAR 77.6B | ZAR 465.94 | 0.43% up | 64% down | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | +0.41% | ZAR 859.1B | ZAR 736.24 | 0.41% up | 74% up | ||
| 18 | Regeneron PharmaceuticalsREGN · Health Care | +0.38% | ZAR 1.71T | ZAR 16,544.10 | 0.38% up | 36% up | ||
| 19 | BioMarin PharmaceuticalBMRN · Health Care | +0.32% | ZAR 195.7B | ZAR 1,010.10 | 0.32% up | 11% up | ||
| 20 | ViatrisVTRS · Health Care | +0.32% | ZAR 404.7B | ZAR 353.04 | 0.32% up | 96% up | ||
| 21 | Amneal PharmaceuticalsAMRX · Health Care | +0.28% | ZAR 127B | ZAR 364.46 | 0.28% up | 83% up | ||
| 22 | GrifolsGRFS · Health Care | +0.23% | ZAR 101.3B | ZAR 148.85 | 0.23% up | 1% up | ||
| 23 | TG TherapeuticsTGTX · Health Care | +0.10% | ZAR 163.3B | ZAR 1,080.13 | 0.10% up | 107% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +0.05% | ZAR 266B | ZAR 4,144.03 | 0.05% up | 37% up | ||
| 25 | Mirum PharmaceuticalsMIRM · Health Care | +0.04% | ZAR 103.3B | ZAR 1,582.86 | 0.04% up | 31% up | ||
| 26 | SanofiSNY · Health Care | +0.02% | ZAR 1.96T | ZAR 818.06 | 0.02% up | 4% down | ||
| 27 | Abbott LaboratoriesABT · Health Care | 0.00% | ZAR 3.12T | ZAR 1,802.69 | 0.00% | 17% down | ||
| 28 | GSKGSK · Health Care | -0.02% | ZAR 1.7T | ZAR 847.14 | 0.02% down | 6% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | -0.03% | ZAR 101.1B | ZAR 5,054.10 | 0.03% down | 43% up | ||
| 30 | Praxis Precision MedicinesPRAX · Health Care | -0.09% | ZAR 146.6B | ZAR 5,244.51 | 0.09% down | 61% up | ||
| 31 | Royalty PharmaRPRX · Health Care | -0.16% | ZAR 678.5B | ZAR 1,179.94 | 0.16% down | 78% up | ||
| 32 | Roivant SciencesROIV · Health Care | -0.28% | ZAR 481.3B | ZAR 664.22 | 0.28% down | 90% up | ||
| 33 | Arrowhead PharmaceuticalsARWR · Health Care | -0.29% | ZAR 104.3B | ZAR 737.61 | 0.29% down | 10% up | ||
| 34 | Eli LillyLLY · Health Care | -0.34% | ZAR 21.62T | ZAR 24,275.22 | 0.34% down | 35% up | ||
| 35 | BridgeBio PharmaBBIO · Health Care | -0.35% | ZAR 256.6B | ZAR 1,317.00 | 0.35% down | 17% up | ||
| 36 | Dianthus TherapeuticsDNTH · Health Care | -0.41% | ZAR 83.9B | ZAR 1,490.63 | 0.41% down | 113% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | -0.41% | ZAR 68.9B | ZAR 503.50 | 0.41% down | 169% up | ||
| 38 | Protagonist TherapeuticsPTGX · Health Care | -0.45% | ZAR 139.4B | ZAR 2,135.66 | 0.45% down | 46% up | ||
| 39 | GenmabGMAB · Health Care | -0.50% | ZAR 548.5B | ZAR 889.64 | 0.50% down | 70% up | ||
| 40 | InsmedINSM · Health Care | -0.53% | ZAR 457.6B | ZAR 2,085.93 | 0.53% down | 40% down | ||
| 41 | PfizerPFE · Health Care | -0.54% | ZAR 2.78T | ZAR 487.24 | 0.54% down | 14% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | -0.55% | ZAR 86.3B | ZAR 1,032.98 | 0.55% down | 20% down | ||
| 43 | United TherapeuticsUTHR · Health Care | -0.59% | ZAR 425.6B | ZAR 9,992.23 | 0.59% down | 23% up | ||
| 44 | Johnson & JohnsonJNJ · Health Care | -0.59% | ZAR 11.48T | ZAR 4,767.59 | 0.59% down | 38% up | ||
| 45 | Takeda PharmaceuticalTAK · Health Care | -0.62% | ZAR 1.18T | ZAR 370.14 | 0.62% down | 54% up | ||
| 46 | AbbVieABBV · Health Care | -0.84% | ZAR 8.83T | ZAR 4,997.32 | 0.84% down | 26% up | ||
| 47 | AstraZenecaAZN · Health Care | -0.98% | ZAR 4.82T | ZAR 3,104.80 | 0.98% down | 2% up | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -1.05% | ZAR 130.6B | ZAR 1,193.10 | 1.05% down | 8% down | ||
| 49 | NovartisNVS · Health Care | -1.18% | ZAR 5.11T | ZAR 2,706.10 | 1.18% down | 25% up | ||
| 50 | Bristol-Myers SquibbBMY · Health Care | -1.22% | ZAR 2.13T | ZAR 1,043.31 | 1.22% down | 34% up | ||
| 51 | Alnylam PharmaceuticalsALNY · Health Care | -1.24% | ZAR 356.2B | ZAR 2,659.64 | 1.24% down | 66% down | ||
| 52 | Axsome TherapeuticsAXSM · Health Care | -1.24% | ZAR 121.5B | ZAR 2,310.32 | 1.24% down | 7% down | ||
| 53 | Ascendis PharmaASND · Health Care | -1.27% | ZAR 302.2B | ZAR 4,607.22 | 1.27% down | 28% up | ||
| 54 | Novo NordiskNVO · Health Care | -1.43% | ZAR 3.04T | ZAR 690.38 | 1.43% down | 17% down | ||
| 55 | Rhythm PharmaceuticalsRYTM · Health Care | -1.46% | ZAR 137.1B | ZAR 1,977.35 | 1.46% down | 13% up | ||
| 56 | Madrigal PharmaceuticalsMDGL · Health Care | -1.50% | ZAR 166.2B | ZAR 7,152.81 | 1.50% down | 24% down | ||
| 57 | Travere TherapeuticsTVTX · Health Care | -1.51% | ZAR 83.1B | ZAR 866.07 | 1.51% down | 44% up | ||
| 58 | BeOne MedicinesONC · Health Care | -1.57% | ZAR 799.6B | ZAR 6,999.79 | 1.57% down | 17% up | ||
| 59 | Merck & CoMRK · Health Care | -1.94% | ZAR 5.96T | ZAR 2,419.24 | 1.94% down | 51% up | ||
| 60 | Edgewise TherapeuticsEWTX · Health Care | -2.40% | ZAR 77.3B | ZAR 706.04 | 2.40% down | 88% up | ||
| 61 | ErascaERAS · Health Care | -3.38% | ZAR 81B | ZAR 230.93 | 3.38% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2078 ZAR).
Questions and answers
Which pharmaceuticals rank first by today's price change?
Legend Biotech (+2.52%), Kiniksa Pharmaceuticals International (+1.71%) and Alkermes (+1.63%) are the top three of the 61 pharmaceuticals ranked by today's price change as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by today's price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by today's price change have a combined market value of ZAR 88.23T as of 18 Nov 2026, 14:51 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.